%0 Journal Article
%T Retinal Prosthesis System for Advanced Retinitis Pigmentosa: A Health Technology Assessment Update
%A Health Quality Ontario
%J Archive of "Ontario Health Technology Assessment Series".
%D 2017
%X Retinitis pigmentosa is a group of inherited disorders characterized by the degeneration of the photoreceptors in the retina, resulting in progressive vision loss. The Argus II system is designed to restore partial functional vision in patients with profound vision loss from advanced retinitis pigmentosa. At present, it is the only treatment option approved by Health Canada for this patient population. In June 2016, Health Quality Ontario published a health technology assessment of the Argus II retinal prosthesis system for patients with advanced retinitis pigmentosa. Based on that assessment, the Ontario Health Technology Advisory Committee recommended against publicly funding the Argus II system for this population. It also recommended that Health Quality Ontario re-evaluate the evidence in 1 year. The objective of this report was to examine new evidence published since the 2016 health technology assessment
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5692298/